Ramon Salazar i Soler, general director of the Catalan Institute of Oncology.
Salazar wanted to “thank the trust placed in the members of the Consell d’Administració” and faces the new stage with “great enthusiasm”. Since joining the institution in 2004, Salazar has assumed different responsibilities and functions in the field of care and research. He is currently running the ICO Medical Oncology Service in L’Hospitalet and is a transversal reference for Digestive Pathology and Medical Oncology at ICO.
He had previously been in charge of the Phase 1 Unit, Head of Corporate Translational Research and Director of Research at the ICO. He has published more than 200 articles in scientific journals and has made more than one hundred presentations at international conferences. It is also necessary to highlight extensive training in clinical management and in senior management of health entities.
What other positions does Salazar hold?
In the teaching field, Salazar is an associate professor and co-director of the Master’s Degree in Advanced Medical Skills (CMA) of the Department of Clinical Sciences of the Faculty of Medicine and Health Sciences of the University of Barcelona.
Salazar has also held management positions in various cooperative oncology groups, both nationally and in Europe, such as the Spanish Group for the Treatment of Digestive Tumors (TTD), the Spanish Group for Neuroendocrine and Endocrine Tumors (Getne), the European Neuroendocrine Tumor Society (ENETs) o el Grup Gastrointestinal de l’European Organisation for Research (Eortc).
The Institut Català d’Oncologia is a public center of excellence in cancer. It deals with the disease in an integral way, since it brings together, within the same organization, prevention, care, specialized training and research. The ICO was created in 1995 by the Department of Health and It is made up of four reference centers: the ICO L’Hospitalet, in the Duran i Reynals Hospital of L’Hospitalet de Llobregat; the ICO Girona, at the Doctor Josep Trueta University Hospital; the ICO Badalona, at the Germans Trias i Pujol University Hospital; and the ICO Camp of Tarragona and Terres de l’Ebre, in the Hospital Universitari Joan XXIII of Tarragona and in the Hospital Verge de la Cinta of Tortosa.
With more than 1,000 professionals, the ICO is the reference center for more than 50 percent of the entire adult population of Catalonia. Every day 64 new cases of cancer are visited and more than 1,000 visits, 508 chemotherapy treatments and 448 radiotherapy are made. In addition, there are some 990 active clinical trials with the participation of more than 1,000 patients.
Although it may contain statements, data or notes from health institutions or professionals, the information contained in Medical Writing is edited and prepared by journalists. We recommend the reader that any questions related to health be consulted with a health professional.
